Atlantic Healthcare initiates FDA rolling submission of its New Drug Application for alicaforsen in the treatment of pouchitis
1st May 2017
Filing of the nonclinical package marks a key milestone in the process towards obtaining marketing approval of alicaforsen for the treatment of pouchitisCambridge, UK; May 1, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging…
Atlantic Healthcare appoints Durbin as Nordic regions distributor of alicaforsen under the Named Patient Programme
24th April 2017
Cambridge, UK, April 24, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces that is has extended its agreement with Durbin plc, for…
Atlantic Healthcare to present at TIDES Conference 2017
20th April 2017
Leadership Team available for meetings in San Diego, April 30 - May 3 Cambridge, UK; April 20, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)…
Atlantic Healthcare announces Chairman to step down as company enters next phase of preparing for product commercialisation
22nd March 2017
Cambridge, UK; March 22, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, is continuing to make good progress towards delivering the…
Atlantic Healthcare confirms alicaforsen targets TLR-9, providing a second mechanism of action to treat new and existing inflammatory indications
28th February 2017
Patent applications filed based on novel discovery, which may provide biological rationale for alicaforsen’s previously observed durable response in inflammatory bowel disease Cambridge, UK; February 28, 2017. Atlantic Healthcare plc (“Atlantic…
Atlantic Healthcare to present at BIO CEO & Investor Conference 2017
6th February 2017
Leadership Team available for meetings in New York, February 13-14 and 21 Cambridge, UK; February 6 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)…